WHO Classification of Tumours Editorial Board. Female Genital Tumours, WHO Classification of Tumours. Vol 4. 5th ed. IARC Press; 2020.

Giordano G, Ferioli E, Guareschi D, Tafuni A. Dedifferentiated endometrial carcinoma: a rare aggressive neoplasm-clinical. Morphol Immunohistochem Featur Cancers. 2023;15:5155. https://doi.org/10.3390/cancers15215155.

Article  CAS  Google Scholar 

Silva EG, Deavers MT, Bodurka DC, Malpica A. Association of low-grade endometrioid carcinoma of the uterus and ovary with carcinoma: a new type of dedifferentiated carcinoma? Int J Gynecol Pathol. 2006;25:52–8.

Article  PubMed  Google Scholar 

Lee SE, Park HY, Shim SH, Kim WY. Dedifferentiated carcinoma with clear cell carcinoma of the endometrium: a case report. Pathol Int. 2017;67(9):472–6. https://doi.org/10.1111/pin.12557.

Article  PubMed  Google Scholar 

Xu Z, Saikia K, Yuan L. Dedifferentiated endometrial carcinoma arising from serous carcinoma: diagnostic challenges and recommendations. Gynecol Oncol Rep. 2023;47: 101188.

Article  PubMed  PubMed Central  Google Scholar 

Han J, Ki EY, Rha SE, et al. Dedifferentiated endometrioid carcinoma of the uterus: report of four cases and literature review. World J Surg Oncol. 2017;15(1):17. https://doi.org/10.1186/s12957-016-1093-0.

Article  PubMed  PubMed Central  Google Scholar 

Tafe LJ, Garg K, Chew I, Tornos C, Soslow RA. Endometrial and ovarian carcinomas with undifferentiated components: clinically aggressive and frequently underrecognized neoplasms. Mod Pathol. 2010;23:781–9.

Article  CAS  PubMed  Google Scholar 

Li Z, Zhao C. Clinicopathologic and immunohistochemical characterization of dedifferentiated endometrioid adenocarcinoma. Appl Immunohistochem Mol Morphol. 2016;24:562–8.

Article  CAS  PubMed  Google Scholar 

Hoang LN, Lee YS, Karnezis AN, Tessier-Cloutier B, Almandani N, Coatham M, Gilks CB, Soslow RA, Stewart CJ, Köbel M, Lee CH. Immunophenotypic features of dedifferentiated endometrial carcinoma - insights from BRG1/INI1-deficient tumours. Histopathology. 2016;69:560–9. https://doi.org/10.1111/his.12989.

Article  PubMed  PubMed Central  Google Scholar 

Yokomizo R, Yamada K, Lida Y, et al. Dedifferentiated endometrial carcinoma: a report of three cases and literature review. Mol-Clin Oncol. 2027;7(6):1008–12.

Google Scholar 

Cherniack AD, Shen H, Walter V, et al. Integrated molecular characterization of uterine carcinosarcoma. Cancer Cell. 2017;31:411–23.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Corr B, Cosgrove C, Spinosa D, Guntupalli S. Endometrial cancer: molecular classification and future treatments. BMJ Med. 2022;1:e000152.

Article  PubMed  PubMed Central  Google Scholar 

Espinosa I, Lee CH, D’Angelo E, Palacios J, Prat J. Undifferentiated and dedifferentiated endometrial carcinomas with pole exonuclease domain mutations have a favourable prognosis. Am J Surg Pathol. 2017;41:1121–8.

Article  PubMed  Google Scholar 

Le DT, Uram JN, Wang H, Bartlett BR, Kemberling H, Eyring AD, Skora AD, Luber BS, Azad NS, Laheru D, et al. PD-1 blockade in tumors with mismatch-repair deficiency. N Engl J Med. 2015;372:2509–20.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Murali R, Davidson B, Fadare O, et al. High-grade endometrial carcinomas: morphologic and immunohistochemical features, diagnostic challenges and recommendations. Int J Gynecol Pathol. 2019;38:S40–63.

Article  PubMed  Google Scholar 

Karnezis AN, Hoang LN, Coatham M, Ravn S, Almadani N, Tessier-Cloutier B, Irving J, Meng B, Li X, Chow C, et al. Loss of switch/sucrose non-fermenting complex protein expression is associated with dedifferentiation in endometrial carcinomas. Mod Pathol. 2016;29:302–14.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Strehl JD, Wachter DL, Fiedler J, Heimerl E, Beckmann MW, Hartmann A, Agaimy A. Pattern of SMARCB1 (INI1) and SMARCA4 (BRG1) in poorly differentiated endometrioid adenocarcinoma of the uterus: analysis of a series with emphasis on a novel SMARCA4-deficient dedifferentiated rhabdoid variant. Ann Diagn Pathol. 2015;19:198–202.

Article  PubMed  Google Scholar 

Cloutier BT, Coatham M, Carey M, et al. SWI/SNF deficiency defines highly aggressive undifferentiated endometrial carcinoma. J Pathol Clin Res. 2020;7(2):144–53.

Article  Google Scholar